Rhythm Pharmaceuticals Overview
Rhythm Pharmaceuticals Target Price
See Rhythm Pharmaceuticals's analyst price targets ($150) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$117.6
Average Target Price
$148.14
26% upside
26% upside7 analysts in the last 4 months
High: $160 | Low: $133
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-05 | Canaccord Genuity | $154 | 31% upside |  |
| 2026-08-05 | National Bank | $160 | 36.1% upside | |
| 2026-07-07 | RBC Capital | $141 | 19.9% upside | |
| 2026-06-16 | Canaccord GenuityWhitney Ijem | $151 | 28.4% upside | |
| 2026-06-15 | Stifel NicolausPaul Matteis | $133 | 13.1% upside | |
| 2026-06-15 | Wells Fargo | $155 | 31.8% upside | |
| 2026-05-07 | Canaccord Genuity | $143 | 21.6% upside | |
| 2026-03-12 | Telsey Advisory | $143 | 21.6% upside | |
| 2026-03-12 | Wells Fargo | $143 | 21.6% upside | |
| 2026-03-03 | JefferiesDennis Ding | $125 | 6.3% upside | |
| 2026-02-26 | Stifel NicolausPaul Matteis | $131 | 11.4% upside | |
| 2026-02-18 | RBC CapitalLisa Walter | $145 | 23.3% upside | |
| 2026-01-20 | H.C. Wainwright | $125 | 6.3% upside | |
| 2026-01-20 | Wells FargoDerek Archila | $145 | 23.3% upside | |
| 2025-12-22 | H.C. WainwrightRaghuram Selvaraju | $123 | 4.6% upside | |
| 2025-12-17 | GuggenheimSeamus Fernandez | $140 | 19% upside | |
| 2025-12-12 | Goldman Sachs | $157 | 33.5% upside | |
| 2025-12-12 | Canaccord GenuityWhitney Ijem | $141 | 19.9% upside | |
| 2025-12-11 | Morgan Stanley | $150 | 27.6% upside | |
| 2025-10-17 | Goldman SachsCorinne Johnson | $139 | 18.2% upside | |
| 2025-10-16 | Morgan Stanley | $129 | 9.7% upside | |
| 2025-09-29 | H.C. WainwrightRaghuram Selvaraju | $110 |  6.5% downside | |
| 2025-09-25 | JMP SecuritiesJonathan Wolleben | $142 | 20.7% upside | |
| 2025-08-05 | Morgan Stanley | $109 | 7.3% downside | |
| 2025-07-10 | OppenheimerLeland Gershell | $110 | 6.5% downside | |
| 2025-07-10 | Goldman SachsCorinne Johnson | $97 | 17.5% downside | |
| 2025-07-09 | Morgan StanleyMichael Ulz | $95 | 19.2% downside | |
| 2025-03-05 | Stifel Nicolaus | $78 | 33.7% downside | |
| 2025-03-03 | H.C. Wainwright | $70 | 40.5% downside | |
| 2025-01-01 | JefferiesDennis Ding | $80 | 32% downside | |
| 2024-12-05 | Goldman SachsCorinne Jenkins | $66 | 43.9% downside | |
| 2024-11-06 | NeedhamAlan Carr | $64 | 45.6% downside | |
| 2024-11-06 | Goldman SachsCorinne Jenkins | $59 | 49.8% downside | |
| 2024-09-18 | H.C. WainwrightRaghuram Selvaraju | $64 | 45.6% downside | |
| 2024-09-17 | JMP SecuritiesJonathan Wolleben | $64 | 45.6% downside | |
| 2024-07-25 | NeedhamAlan Carr | $55 | 53.2% downside | |
| 2022-11-10 | Goldman Sachs | $35 | 70.2% downside | |
| 2022-08-07 | Goldman SachsCorinne Jenkins | $28 | 76.2% downside | |
| 2022-07-12 | Goldman SachsCorinne Jenkins | $6 | 94.9% downside | |
| 2022-06-17 | Needham | $25 | 78.7% downside | |
| 2022-06-17 | Stifel NicolausDae Gon Ha | $25 | 78.7% downside | |